Lesson 14 • 17 Jul 2025
Analyzing Bladder Cancer Treatments, Efficacy Of Gemcitabine, Docetaxel, And TAR-200
Course overview
This course covers the management of intermediate risk NMIBC, including diagnostic strategies, treatment advancements, BCG refractory cases, adjuvant therapies, with insights from leading experts in oncology and urology.
1.5 hours, 17 lessons
Lessons
Patient-Centered Treatment Strategies with Dr. Kelly Bree
Lesson 1
Risk stratification for patients with intermediate risk bladder cancer
Lesson 2
Quality of life, counseling, and treatment strategies for bladder cancer patients
Lesson 3
Patient preparation and in-office procedures for low-grade tumors
Lesson 4
Criteria for in-office fulguration, recurrence timelines, and patient resources for bladder cancer
Lesson 5
Patient-centered treatment options and research for intermediate risk NMIBC
Intravesical Therapies for Intermediate Risk Bladder Cancer with Dr. Lindsey Herrel
Lesson 6
Definitions, patient care strategies, and treatment options for intermediate risk bladder cancer
Lesson 7
Patient management challenges and new FDA-approved agents for bladder cancer
Lesson 8
Delivery methods in bladder cancer treatments, focusing on quality of life
Lesson 9
Cost-effective therapeutic approaches to NMIBC
Lesson 10
Improving intermediate risk disease outcomes through guidelines, biomarkers, and patient counseling
BCG Shortage: Salvaging Bladder Cancer Care with Dr. Amy Luckenbaugh
Lesson 11
The Challenge of BCG Shortages in Bladder Cancer Treatment
Lesson 12
Strategies For Managing BCG Shortages In Bladder Cancer Therapy
Lesson 13
New Therapies For Intermediate Risk Patients Beyond Traditional BCG Treatments
Lesson 14
Analyzing Bladder Cancer Treatments, Efficacy Of Gemcitabine, Docetaxel, And TAR-200
Lesson 15
New Treatments Options For BCG Refractory Bladder Cancer
Lesson 16
BCG Alternatives, Patient Quality Of Life, And Future Guidelines
Lesson 17
Supply Chain Resilience And BCG Allocation Strategies Amid Shortages
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.